Literature DB >> 20682624

The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis.

Sami Banerjee1, Arnaud Friggeri, Gang Liu, Edward Abraham.   

Abstract

HMGB1 was described originally as a nuclear protein involved in DNA binding and transcriptional regulation. However, HMGB1 also has an extracellular role as a potent mediator of inflammation and can diminish the uptake of apoptotic cells by phagocytes, a process called efferocytosis. To explore the mechanism responsible for the ability of HMGB1 to inhibit efferocytosis, we examined the role of the C-terminal acidic tail, a region of HMGB1 that has been shown to participate in specific intramolecular interactions. Deletion of the C-terminal tail abrogated the ability of HMGB1 to decrease murine macrophage ingestion of apoptotic neutrophils and to diminish phagocytosis-induced activation of Erk and Rac-1 in macrophages. We found that RAGE plays a major role in efferocytosis, and deletion of the C-terminal tail of HMGB1 prevented binding of HMGB1 to RAGE but not to other macrophage receptors involved in efferocytosis, such as the α(V)β(3) integrin. Whereas HMGB1 decreased ingestion of apoptotic neutrophils significantly by alveolar macrophages under in vivo conditions in the lungs of mice, this effect was lost when the C-terminal acidic tail was absent from HMGB1. These results demonstrate that the HMGB1 C-terminal tail is responsible for the inhibitory effects of HMGB1 on phagocytosis of apoptotic neutrophils under in vitro and in vivo conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682624      PMCID: PMC3072233          DOI: 10.1189/jlb.0510262

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  46 in total

1.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 2.  Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.

Authors:  Helena Erlandsson Harris; Ulf Andersson
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

3.  The inhibitory effect of HMGB-1 protein on the repair of cisplatin-damaged DNA is accomplished through the acidic domain.

Authors:  Elena Mitkova; Iva Ugrinova; Iliya G Pashev; Evdokia A Pasheva
Journal:  Biochemistry       Date:  2005-04-19       Impact factor: 3.162

4.  Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.

Authors:  Vedat Schwenger; Christian Morath; Alexander Salava; Kerstin Amann; Yuri Seregin; Reinhold Deppisch; Eberhard Ritz; Angelika Bierhaus; Peter P Nawroth; Martin Zeier
Journal:  J Am Soc Nephrol       Date:  2005-11-30       Impact factor: 10.121

5.  Both high mobility group (HMG)-boxes and the acidic tail of HMGB1 regulate recombination-activating gene (RAG)-mediated recombination signal synapsis and cleavage in vitro.

Authors:  Serge Bergeron; Tina Madathiparambil; Patrick C Swanson
Journal:  J Biol Chem       Date:  2005-07-01       Impact factor: 5.157

Review 6.  HMG proteins: dynamic players in gene regulation and differentiation.

Authors:  Marco E Bianchi; Alessandra Agresti
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

7.  HMG-1 as a late mediator of endotoxin lethality in mice.

Authors:  H Wang; O Bloom; M Zhang; J M Vishnubhakat; M Ombrellino; J Che; A Frazier; H Yang; S Ivanova; L Borovikova; K R Manogue; E Faist; E Abraham; J Andersson; U Andersson; P E Molina; N N Abumrad; A Sama; K J Tracey
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

Review 8.  HMGB1: guiding immunity from within.

Authors:  Ingrid E Dumitriu; Paramita Baruah; Angelo A Manfredi; Marco E Bianchi; Patrizia Rovere-Querini
Journal:  Trends Immunol       Date:  2005-07       Impact factor: 16.687

9.  HMGB1 contributes to the development of acute lung injury after hemorrhage.

Authors:  Jae Yeol Kim; Jong Sung Park; Derek Strassheim; Ivor Douglas; Fernando Diaz del Valle; Karim Asehnoune; Sanchayita Mitra; Sang Hyun Kwak; Shingo Yamada; Ikuro Maruyama; Akitoshi Ishizaka; Edward Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-01-07       Impact factor: 5.464

10.  The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes.

Authors:  Stefan Knapp; Susanne Müller; Giuseppe Digilio; Tiziana Bonaldi; Marco E Bianchi; Giovanna Musco
Journal:  Biochemistry       Date:  2004-09-28       Impact factor: 3.162

View more
  22 in total

1.  Intracellular HMGB1 negatively regulates efferocytosis.

Authors:  Sami Banerjee; Andressa de Freitas; Arnaud Friggeri; Jaroslaw W Zmijewski; Gang Liu; Edward Abraham
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

2.  Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing.

Authors:  Jean-Marc Tadié; Hong-Beom Bae; Sami Banerjee; Jaroslaw W Zmijewski; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-19       Impact factor: 4.249

3.  Poly(ADP-ribosyl)ation of high mobility group box 1 (HMGB1) protein enhances inhibition of efferocytosis.

Authors:  Kasey Davis; Sami Banerjee; Arnaud Friggeri; Celeste Bell; Edward Abraham; Mourad Zerfaoui
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

4.  HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia.

Authors:  Nabanita Das; Varun Dewan; Peter M Grace; Robin J Gunn; Ryo Tamura; Netanel Tzarum; Linda R Watkins; Ian A Wilson; Hang Yin
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

Review 5.  High-mobility group box 1, oxidative stress, and disease.

Authors:  Daolin Tang; Rui Kang; Herbert J Zeh; Michael T Lotze
Journal:  Antioxid Redox Signal       Date:  2011-04-01       Impact factor: 8.401

6.  Participation of the receptor for advanced glycation end products in efferocytosis.

Authors:  Arnaud Friggeri; Sami Banerjee; Subrata Biswas; Andressa de Freitas; Gang Liu; Angelika Bierhaus; Edward Abraham
Journal:  J Immunol       Date:  2011-04-18       Impact factor: 5.422

7.  Extracellular histones inhibit efferocytosis.

Authors:  Arnaud Friggeri; Sami Banerjee; Na Xie; Huachun Cui; Andressa De Freitas; Mourad Zerfaoui; Hervé Dupont; Edward Abraham; Gang Liu
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

8.  HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.

Authors:  Jean-Marc Tadie; Hong-Beom Bae; Shaoning Jiang; Dae Won Park; Celeste P Bell; Huan Yang; Jean-Francois Pittet; Kevin Tracey; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 10.  Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.

Authors:  Fleur Schaper; Johanna Westra; Marc Bijl
Journal:  Mol Med       Date:  2014-03-13       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.